Recommending pneumococcal vaccination for all 50-year-olds prevents the most disease in underserved minorities and the general population.
A novel antibiotic, lefamulin, may not be inferior to moxifloxacin in efficacy and safety for the treatment of community-acquired bacterial pneumonia.
Use of rapid polymerase chain reaction-based diagnostic tests for MRSA significantly reduced the use of vancomycin and linezolid in patients who were mechanically ventilated with suspected pneumonia at risk for MRSA.
Expert opinions on judgment-based criteria for the assessment of antimicrobial treatment efficacy in HABP and VABP are heterogenous.
A new algorithm can search administrative data for individuals with HAP and VAP, who are at significant risk for carbapenem-resistant infection.